These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38133405)

  • 1. Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine.
    Balayssac D; Durif J; Lambert C; Dalbos C; Chapuy E; Etienne M; Demiot C; Busserolles J; Martin V; Sapin V
    Toxics; 2023 Dec; 11(12):. PubMed ID: 38133405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
    Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
    Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2.
    Cho HS; Choi YI; Park SU; Han YS; Kwon J; Jung SJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
    Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
    Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
    Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy.
    Cavaletti G; Pizzamiglio C; Man A; Engber TM; Comi C; Wilbraham D
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice.
    Basu A; Yang JY; Tsirukis VE; Loiacono A; Koch G; Khwaja IA; Krishnamurthy M; Fazio N; White E; Jha A; Shah S; Takmil C; Bagdas D; Demirer A; Master A; Natke E; Honkanen R; Huang L; Rigas B
    Front Neurosci; 2023; 17():1240372. PubMed ID: 38347876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors.
    Selvy M; Mattévi C; Dalbos C; Aissouni Y; Chapuy E; Martin PY; Collin A; Richard D; Dumontet C; Busserolles J; Condé S; Balayssac D
    Biomed Pharmacother; 2022 May; 149():112915. PubMed ID: 35635358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice.
    Sałat K; Furgała A; Sałat R
    Biomed Pharmacother; 2019 Mar; 111():882-890. PubMed ID: 30841467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase.
    Janes K; Doyle T; Bryant L; Esposito E; Cuzzocrea S; Ryerse J; Bennett GJ; Salvemini D
    Pain; 2013 Nov; 154(11):2432-2440. PubMed ID: 23891899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients.
    Mahmoudpour SH; Bandapalli OR; da Silva Filho MI; Campo C; Hemminki K; Goldschmidt H; Merz M; Försti A
    BMC Cancer; 2018 Aug; 18(1):820. PubMed ID: 30111286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
    Meregalli C; Fumagalli G; Alberti P; Canta A; Chiorazzi A; Monza L; Pozzi E; Carozzi VA; Blennow K; Zetterberg H; Cavaletti G; Marmiroli P
    Arch Toxicol; 2020 Jul; 94(7):2517-2522. PubMed ID: 32333051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy.
    Huehnchen P; Schinke C; Bangemann N; Dordevic AD; Kern J; Maierhof SK; Hew L; Nolte L; Körtvelyessy P; Göpfert JC; Ruprecht K; Somps CJ; Blohmer JU; Sehouli J; Endres M; Boehmerle W
    JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35133982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy.
    Meregalli C; Fumagalli G; Alberti P; Canta A; Carozzi VA; Chiorazzi A; Monza L; Pozzi E; Sandelius Å; Blennow K; Zetterberg H; Marmiroli P; Cavaletti G
    Exp Neurol; 2018 Sep; 307():129-132. PubMed ID: 29908147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
    Mansooralavi N; Khomula EV; Levine JD
    Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen suppresses paclitaxel-, vincristine-, and bortezomib-induced neuropathy via inhibition of the protein kinase C/extracellular signal-regulated kinase pathway.
    Tsubaki M; Takeda T; Matsumoto M; Kato N; Yasuhara S; Koumoto YI; Imano M; Satou T; Nishida S
    Tumour Biol; 2018 Oct; 40(10):1010428318808670. PubMed ID: 30360692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
    J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin.
    Burgess BL; Cho E; Honigberg L
    Sci Rep; 2022 Sep; 12(1):15593. PubMed ID: 36114333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
    Tsubota M; Fukuda R; Hayashi Y; Miyazaki T; Ueda S; Yamashita R; Koike N; Sekiguchi F; Wake H; Wakatsuki S; Ujiie Y; Araki T; Nishibori M; Kawabata A
    J Neuroinflammation; 2019 Oct; 16(1):199. PubMed ID: 31666085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions.
    Rodwin RL; Siddiq NZ; Ehrlich BE; Lustberg MB
    Front Pain Res (Lausanne); 2022; 3():864910. PubMed ID: 35360655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.